Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin. [electronic resource]
Producer: 20161213Description: 508-13 p. digitalISSN:- 1569-8041
- Antibiotics, Antineoplastic -- adverse effects
- Cell Line, Tumor
- DNA, Viral -- blood
- Depsipeptides -- adverse effects
- Epstein-Barr Virus Infections -- pathology
- Female
- Herpesvirus 4, Human -- drug effects
- Histone Deacetylase Inhibitors -- adverse effects
- Humans
- Lymphoma, Extranodal NK-T-Cell -- drug therapy
- Male
- Middle Aged
- Pilot Projects
- Prospective Studies
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.